| Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung (NCT01759303) | Emerald Clinical Inc. | 2013-04-01 |
| Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors (NCT02100891) | Monica Thakar | 2013-03-20 |
| Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma (NCT01882231) | Vanderbilt-Ingram Cancer Center | 2013-03-01 |
| Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors (NCT01661400) | Washington University School of Medicine | 2012-10-26 |
| Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy (NCT01674101) | St. Jude Children's Research Hospital | 2012-09-01 |
| A Clinical Research on the Relation of Blood Drug Concentration and Calcium Folinate Rescued in High-dose MTX Therapy (NCT01758666) | Tianjin Medical University Cancer Institute and Hospital | 2012-09-01 |
| Trial With Gemcitabine and Rapamycin in Second Line of Metastatic Osteosarcoma (NCT02429973) | Broto, Javier Martín, M.D. | 2012-07-01 |
| Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting (NCT01492569) | Stanford University | 2012-05-01 |
| Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia (NCT01491594) | Duke University | 2012-04-01 |
| Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors (NCT01518413) | HMeany | 2011-12-01 |
| Surveillance Study of Patients With Newly Diagnosed Osteosarcoma (NCT01194284) | Millennium Pharmaceuticals, Inc. | 2011-12-01 |
| Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI (NCT01336803) | Heike E Daldrup-Link | 2011-08-01 |
| ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma (NCT01459484) | Italian Sarcoma Group | 2011-06-23 |
| Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors (NCT01331135) | Emory University | 2011-04-01 |
| Therapy Trial to Determine the Safety and Efficacy of Heavy Ion Radiotherapy in Patients With Osteosarcoma (NCT01005043) | University Hospital Heidelberg | 2010-12-01 |
| Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies (NCT01242072) | Alaunos Therapeutics | 2010-11-01 |
| RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia (NCT01236586) | National Cancer Institute (NCI) | 2010-10-08 |
| Outpatient Administration of High Dose Methotrexate (HD MTX) in Patients With Osteosarcoma (NCT01176981) | The Hospital for Sick Children | 2010-10-01 |
| Diffusion Study on Patients With Osteosarcoma (NCT01615640) | Klinikum Stuttgart | 2010-09-01 |
| A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response (NCT01258634) | University of Chicago | 2010-07-01 |
| A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors (NCT01130623) | National Cancer Institute (NCI) | 2010-05-10 |
| Markers of Anthracycline-Related Cardiac Muscle Injury (NCT01112800) | St. Jude Children's Research Hospital | 2010-05-01 |
| HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors (NCT00931931) | Timothy Cripe | 2010-03-01 |
| Genetic Biomarkers in Tissue Samples From Patients With Osteosarcoma (NCT01807143) | Children's Oncology Group | 2010-01-01 |
| Methionine PET/CT Studies In Patients With Cancer (NCT00840047) | St. Jude Children's Research Hospital | 2009-07-20 |
| Adjuvant High-Dose Thiotepa and Stem Cell Rescue Associated With Conventional Chemotherapy in Relapsed Osteosarcoma (NCT00978471) | Centre Leon Berard | 2009-07-01 |
| Osteosarcoma and Ewing Sarcoma Treatment Response Assessment With Functional MRI Imaging in Children and Young Adults (NCT01780779) | Universitaire Ziekenhuizen KU Leuven | 2009-06-01 |
| A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung (NCT00752206) | Sarcoma Alliance for Research through Collaboration | 2009-03-01 |
| A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma (NCT01002092) | Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd | 2009-02-01 |
| Informed Consent in Pediatric Cancer Trials (NCT00923650) | National Cancer Institute (NCI) | 2008-12-09 |
| A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma (NCT00743496) | St. Jude Children's Research Hospital | 2008-10-08 |
| High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma (NCT00634322) | BTG International Inc. | 2008-10-01 |
| A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced Sarcoma (NCT00743509) | University of Michigan Rogel Cancer Center | 2008-08-01 |
| A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma (NCT00667342) | St. Jude Children's Research Hospital | 2008-06-03 |
| Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma (NCT00691236) | Tata Memorial Hospital | 2008-05-01 |
| Pilot Study of Curcumin Formulation and Ashwagandha Extract in Advanced Osteosarcoma (NCT00689195) | Tata Memorial Hospital | 2008-05-01 |
| Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze (NCT00634504) | BTG International Inc. | 2008-05-01 |
| Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy (NCT00673179) | M.D. Anderson Cancer Center | 2008-05-01 |
| Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma (NCT00899275) | Children's Oncology Group | 2008-02-04 |
| A Study to Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720) (NCT00617890) | Merck Sharp & Dohme LLC | 2008-02-01 |
| Mifamurtide (L-MTP-PE) for High-Risk Osteosarcoma (NCT00631631) | Millennium Pharmaceuticals, Inc. | 2008-01-01 |
| Sorafenib in Relapsed High Grade Osteosarcoma (NCT00889057) | Italian Sarcoma Group | 2008-01-01 |
| Phase II Study of Intravenous Rexin-G in Osteosarcoma (NCT00572130) | Epeius Biotechnologies | 2007-12-01 |
| Chemotherapy for Patients With Osteosarcoma (NCT00523419) | Eli Lilly and Company | 2007-09-01 |
| A Study of Pemetrexed in Children With Recurrent Cancer (NCT00520936) | Eli Lilly and Company | 2007-09-01 |
| Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays? (NCT02022358) | University College, London | 2007-07-01 |
| Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung (NCT00503295) | Oncolytics Biotech | 2007-06-01 |
| Collecting and Storing Tissue From Young Patients With Cancer (NCT00898755) | Children's Oncology Group | 2007-03-05 |
| Development of Indices Predicting Response to Pre-operative Chemotherapy in Osteosarcoma Patients (NCT00686738) | National Cancer Center, Korea | 2007-02-01 |
| Clinical Orthopaedic Data Bank (Acute and Chronic) (NCT00411060) | University of Florida | 2007-01-01 |
| HGS-ETR2 to Treat Children With Solid Tumors (NCT00428272) | National Cancer Institute (NCI) | 2006-12-04 |
| ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors (NCT00132158) | St. Jude Children's Research Hospital | 2005-09-01 |
| Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED) (NCT00093080) | Merck Sharp & Dohme LLC | 2004-10-01 |
| Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma (NCT00586846) | Memorial Sloan Kettering Cancer Center | 2003-07-01 |
| Huntsman Biopsy Study (NCT00615329) | State University of New York - Upstate Medical University | 2003-04-01 |
| Machine Learning Applied to EHRs Data of Patients With Sarcoma (NCT07215728) | University of Milano Bicocca | 2003-01-01 |
| Inheritance of Osteosarcoma & Paget's Disease Through Chromosome 18: (NCT00615628) | State University of New York - Upstate Medical University | 2002-04-01 |
| European Study in Bone Sarcoma Patients Over 40 Years (NCT02986503) | Italian Sarcoma Group | 2002-01-01 |
| Eligibility Screening for a NCI Pediatric Oncology Branch Research Study (NCT00026780) | National Cancer Institute (NCI) | 2001-09-24 |
| Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy (NCT00187109) | St. Jude Children's Research Hospital | 2000-06-01 |
| Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies (NCT00038207) | M.D. Anderson Cancer Center | 2000-06-01 |
| Oncological and Functional Outcomes in Lower Limb Osteosarcoma Pediatric Patient (NCT06162962) | Changye Zou | 2000-01-01 |
| Detection of Circulating Osteosarcoma Tumor Cells in the Blood of Patients Using the Polymerase Chain Reaction (NCT00588510) | Memorial Sloan Kettering Cancer Center | 2000-01-01 |
| Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma (NCT00145639) | St. Jude Children's Research Hospital | 1999-05-01 |
| Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma (NCT00504140) | M.D. Anderson Cancer Center | 1996-11-01 |
| A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma (NCT00001436) | National Cancer Institute (NCI) | 1995-05-01 |
| Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children (NCT00180908) | Gustave Roussy, Cancer Campus, Grand Paris | 1994-06-01 |
| Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III Study (NCT00001217) | National Cancer Institute (NCI) | 1987-05-01 |
| A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors (NCT00001209) | National Cancer Institute (NCI) | 1986-10-01 |
| Clinical Studies of Gemcitabine-Oxaliplatin (NCT00407433) | Gustave Roussy, Cancer Campus, Grand Paris | |
| BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast (NCT04091295) | Aveni Foundation | |
| Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma (NCT04571229) | Memorial Sloan Kettering Cancer Center | |